Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-16T05:38:10.091Z Has data issue: false hasContentIssue false

Prevalence of anti-basal ganglia antibodies in adultobsessive–compulsive disorder: cross-sectional study

Published online by Cambridge University Press:  02 January 2018

Timothy R. J. Nicholson*
Affiliation:
National Institute of Health Research Specialist Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and The Institute of Psychiatry, King's College London
Sumudu Ferdinando
Affiliation:
South West London and St George's NHS Trust, St George's, London
Ravikumar B. Krishnaiah
Affiliation:
Hertfordshire Partnership NHS Foundation Trust, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire
Sophie Anhoury
Affiliation:
National Institute of Health Research Specialist Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and The Institute of Psychiatry, King's College London
Belinda R. Lennox
Affiliation:
Department of Psychiatry, University of Cambridge, Cambridge
David Mataix-Cols
Affiliation:
National Institute of Health Research Specialist Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and The Institute of Psychiatry, King's College London
Anthony Cleare
Affiliation:
National Institute of Health Research Specialist Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and The Institute of Psychiatry, King's College London
David M. Veale
Affiliation:
National Institute of Health Research Specialist Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and The Institute of Psychiatry, King's College London
Lynne M. Drummond
Affiliation:
South West London and St George's NHS Trust, St George's, London
Naomi A. Fineberg
Affiliation:
Hertfordshire Partnership NHS Foundation Trust, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire
Andrew J. Church
Affiliation:
Department of Neuroinflammation, Institute of Neurology, University College London
Gavin Giovannoni
Affiliation:
Queen Mary University of London, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, London
Isobel Heyman
Affiliation:
National Institute of Health Research Specialist Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and The Institute of Psychiatry, King's College London and National, and Specialist OCD Clinic, Children's Department, Maudsley Hospital, London, UK
*
Tim Nicholson, Section of Cognitive Neuropsychiatry,Department of Psychological Medicine, Institute of Psychiatry, De CrespignyPark, Denmark Hill, London SE5 8AF. Email: timothy.nicholson@kcl.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Background

Symptoms of obsessive–compulsive disorder (OCD) have been described in neuropsychiatric syndromes associated with streptococcal infections. It is proposed that antibodies raised against streptococcal proteins cross-react with neuronal proteins (antigens) in the brain, particularly in the basal ganglia, which is a brain region implicated in OCD pathogenesis.

Aims

To test the hypothesis that post-streptococcal autoimmunity, directed against neuronal antigens, may contribute to the pathogenesis of OCD in adults.

Method

Ninety-six participants with OCD were tested for the presence of anti-streptolysin-O titres (ASOT) and the presence of anti-basal ganglia antibodies (ABGA) in a cross-sectional study. The ABGA were tested for with western blots using three recombinant antigens; aldolase C, enolase and pyruvate kinase. The findings were compared with those in a control group of individuals with depression (n = 33) and schizophrenia (n = 17).

Results

Positivity for ABGA was observed in 19/96 (19.8%) participants with OCD compared with 2/50 (4%) of controls (Fisher's exact testP = 0.012). The majority of positive OCD sera (13/19) had antibodies against the enolase antigen. No clinical variables were associated with ABGA positivity. Positivity for ASOT was not associated with ABGA positivity nor found at an increased incidence in participants with OCD compared with controls.

Conclusions

These findings support the hypothesis that central nervous system autoimmunity may have an aetiological role in some adults with OCD. Further study is required to examine whether the antibodies concerned are pathogenic and whether exposure to streptococcal infection in vulnerable individuals is a risk factor for the development of OCD.

Information

Type
Papers
Copyright
Copyright © Royal College of Psychiatrists, 2012 
Figure 0

TABLE 1Comparison between obsessive–compulsive disorder (OCD) and control group for key variables

Figure 1

TABLE 2Characteristics of obsessive–compulsive disorder (OCD) group according to presence of anti-basal ganglia antibodies (ABGA)

Figure 2

TABLE 3Lifetime history of various conditions in the obsessive–compulsive disorder (OCD) group according to presence of anti-basal ganglia antibodies (ABGA)

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.